Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SRX Global Inc. (SRXH : AMEX)

• Company Description    SRx Health Solutions Inc. operates as a healthcare service provider specializing in the Specialty Pharmacy segment of the pharmaceutical industry. SRx Health Solutions Inc., formerly known as Better Choice Company Inc., is based in TAMPA, Fla. Number of Employees: 11

• Price / Volume Information    Yesterday's Closing Price: $1.80 Daily Weekly Monthly 20 Day Moving Average: 10,330,673 shares Shares Outstanding: 9.86 (millions) Market Capitalization: $17.74 (millions) Beta: 0.73 52 Week High: $36.20 52 Week Low: $0.96 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -66.86% -67.12% 12 Week -74.80% -75.42% Year To Date -86.83% -87.83%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 801 US Highway 1 - North Palm Beach,FL 33408 USA ph: 212-896-1254 fax: - valter@kcsa.com https://srxhealth.com

• General Corporate Information    Officers Kent Cunningham - Chief Executive Officer Carolina Martinez - Chief Financial Officer; Secretary and Treasurer Joshua Epstein - Director Simon Conway - Director Sammy Dorf - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 08771Y501 SIC: 2080 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/26 Next Expected EPS Date: 09/29/26 Share - Related Items Shares Outstanding: 9.86 Most Recent Split Date: 7.00 (0.02:1) Beta: 0.73 Market Capitalization: $17.74 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 07/22/2026 - $0.05 Next EPS Report Date: 09/29/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.82 Price/Cash Flow: - Price / Sales: 0.48 EPS Growth vs. Year Ago Period: 94.59% vs. Previous Quarter: 88.24% Sales Growth vs. Year Ago Period: -51.96% vs. Previous Quarter: 22.52% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - - 03/31/26 - -72.94 12/31/25 - -71.54 Current Ratio 06/30/26 - - 03/31/26 - 1.72 12/31/25 - 0.80 Quick Ratio 06/30/26 - - 03/31/26 - 1.64 12/31/25 - 0.74 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - -184.88 12/31/25 - -104.54 Book Value 06/30/26 - - 03/31/26 - 2.21 12/31/25 - -6.33 Inventory Turnover 06/30/26 - - 03/31/26 - 3.36 12/31/25 - 2.07 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©